• Discovery may help boost peptide design

    News / 6 May 2021

    Research led by EMBL Australia group leader Max Cryle has revealed a key aspect of peptide machineries, advancing his work in countering the global threat of antimicrobial resistance and having broad implications for health and industry.

    Read More
  • Lights out for Parkinson's disease

    News / 15 April 2021

    Research led by EMBL Australia group leader Dr Harald Janovjak has revealed the potential of optogenetics - a relatively new and rapidly evolving technology - to treat Parkinson's disease.
    Read More
  • EMBL Australia Newsletter - March 2021

    Newsletters / 17 March 2021

    News this quarter:

    • A tribute to Scientia Professor Katharina Gaus FAHMS
    • Reversing severe muscle wasting in disease, ageing & trauma
    • Hint as to how SARS-CoV-2 might subvert immune defences
    • Enabling the early and accurate diagnosis of Parkinson’s disease
    • More than $4.8m awarded to EMBL Australia researchers in NHMRC Ideas Grants
    • This protein empowers cancer cells – targeting it could kickstart new therapies
    • Professor Ian Smith to chair the EMBL Australia Council
    • Innovative research takes us one step closer to developing an effective malaria vaccine
    • Did you know you can access EMBL’s cutting-edge scientific services?
    • Get to know: Dr Vaishnavi Ananthanarayanan


    And more:

    • Job opportunities
    • Upcoming events
    • Recent publications
    View Newsletter
  • EMBL Australia - 2020 Highlights

    Annual Reports / 14 March 2021

    Despite the challenges and disruptions imposed by the global COVID-19 pandemic, the EMBL Australia Partner Laboratory Network continued to produce fantastic science, attract highly competitive research grants and grow in size. Many of our researchers contributed scientifically to the international battle against coronavirus and continued to build up Australia's research infrastructure capabilities across the various PLN host institutions.
    Read More